National Cancer Institute date last accessed 5 April 2011
National Cancer Institute. Surveillance Epidemiology and End Results (SEER) Fact Sheets. http://seer.cancer.gov/statfacts/html/bones.html (date last accessed 5 April 2011).
National Institute for Health and Clinical Excellence. NICE guidance: improving outcomes for patients with sarcomas, 2006. http://www.guidance.nice. org.uk/CSGSarcoma/Guidance/pdf/English (date last accessed 5 April 2011).
Factors associated with tumor volume and primary metastases in Ewing tumors: Results from the (EI)CESS studies
DOI 10.1023/A:1008357018737
Hense HW, Ahrens S, Paulussen M, Lehnert M, Jürgens H. Factors associated with tumour volume and primary metastases in Ewing tumors: results from the (EI)CESS studies. Ann Oncol 1999;10:1073-7. (Pubitemid 29482462)
National Institute for Health and Clinical Excellence. CG27 referral for suspected cancer: full guideline, 2005. http://guidance.nice.org.uk/CG27/ Guidance (date last accessed 5 April 2011).
Haematological malignancies in a general population, based on information collected from a population study, hospital records, and the Cancer Registry of Norway. The Tromso study
DOI 10.1034/j.1600-0609.2002.01544.x
Skjelbakken T, Løchen ML, Dahl IM. Haematological malignancies in a general population, based on information collected from a population study, hospital records, and the Cancer Registry of Norway: the Trømso Study. Eur J Haematol 2002;69:67-75. (Pubitemid 35178105)
The prognosis for patients with osteosarcoma who have received prior manipulative therapy
Wu PK, Chen WM, Lee OK, et al. The prognosis for patients with osteosarcoma who have received prior manipulative therapy. J Bone Joint Surg [Br] 2010;92-B:1580-5.